发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report ASCO GI 2024最新文献

筛选
英文 中文
SKYSCRAPER-08: Adding tiragolumab to oesophageal cancer regimen improves outcomes SKYSCRAPER-08：在食管癌治疗方案中加入替拉单抗可改善预后
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/18b8fcc4
Robert van den Heuvel
{"title":"SKYSCRAPER-08: Adding tiragolumab to oesophageal cancer regimen improves outcomes","authors":"Robert van den Heuvel","doi":"10.55788/18b8fcc4","DOIUrl":"https://doi.org/10.55788/18b8fcc4","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"116 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALPACA: Promising results for dose de-escalated regimen of gemcitabine/nab-paclitaxel in metastatic PDAC ALPACA：吉西他滨/纳布-紫杉醇剂量递增方案治疗转移性 PDAC 取得良好效果
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/9d60f094
Robert van den Heuvel
{"title":"ALPACA: Promising results for dose de-escalated regimen of gemcitabine/nab-paclitaxel in metastatic PDAC","authors":"Robert van den Heuvel","doi":"10.55788/9d60f094","DOIUrl":"https://doi.org/10.55788/9d60f094","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"16 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New standard-of-care for locally advanced oesophageal squamous cell carcinoma? 局部晚期食道鳞状细胞癌的新治疗标准？
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/209ec57e
Robert van den Heuvel
{"title":"New standard-of-care for locally advanced oesophageal squamous cell carcinoma?","authors":"Robert van den Heuvel","doi":"10.55788/209ec57e","DOIUrl":"https://doi.org/10.55788/209ec57e","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"96 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising efficacy data for next-gen FGFR inhibitor tinengotinib in CCA 新一代表皮生长因子受体（FGFR）抑制剂替能替尼治疗CCA的疗效数据令人鼓舞
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/c63717a3
Robert van den Heuvel
{"title":"Promising efficacy data for next-gen FGFR inhibitor tinengotinib in CCA","authors":"Robert van den Heuvel","doi":"10.55788/c63717a3","DOIUrl":"https://doi.org/10.55788/c63717a3","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"17 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic or open surgery in low rectal cancer? 低位直肠癌采用腹腔镜手术还是开腹手术？
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/3cf9a512
Robert van den Heuvel
{"title":"Laparoscopic or open surgery in low rectal cancer?","authors":"Robert van den Heuvel","doi":"10.55788/3cf9a512","DOIUrl":"https://doi.org/10.55788/3cf9a512","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"15 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adding docetaxel to standard-of-care does not improve outcomes in gastric cancer 在标准治疗的基础上增加多西他赛并不能改善胃癌的治疗效果
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/1bd52b11
Robert van den Heuvel
{"title":"Adding docetaxel to standard-of-care does not improve outcomes in gastric cancer","authors":"Robert van den Heuvel","doi":"10.55788/1bd52b11","DOIUrl":"https://doi.org/10.55788/1bd52b11","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"53 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CheckMate 648: More quality time for patients with oesophageal cancer on nivolumab CheckMate 648：为接受尼伐单抗治疗的食道癌患者提供更多优质时间
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/5ec6a468
Robert van den Heuvel
{"title":"CheckMate 648: More quality time for patients with oesophageal cancer on nivolumab","authors":"Robert van den Heuvel","doi":"10.55788/5ec6a468","DOIUrl":"https://doi.org/10.55788/5ec6a468","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"69 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EMERALD-1: TACE plus immunotherapy meets primary endpoint in unresectable HCC EMERALD-1： TACE加免疫疗法达到不可切除性HCC的主要终点
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/faca026c
Robert van den Heuvel
{"title":"EMERALD-1: TACE plus immunotherapy meets primary endpoint in unresectable HCC","authors":"Robert van den Heuvel","doi":"10.55788/faca026c","DOIUrl":"https://doi.org/10.55788/faca026c","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"241 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140457793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CheckMate 8HW: Excellent results for nivolumab plus ipilimumab in MSI-H/dMMR mCRC CheckMate 8HW：nivolumab联合ipilimumab治疗MSI-H/dMMR mCRC效果极佳
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/3c124e34
Robert van den Heuvel
{"title":"CheckMate 8HW: Excellent results for nivolumab plus ipilimumab in MSI-H/dMMR mCRC","authors":"Robert van den Heuvel","doi":"10.55788/3c124e34","DOIUrl":"https://doi.org/10.55788/3c124e34","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"53 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139894454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MATTERHORN: FLOT plus durvalumab leads to high pCR rate in gastric cancer MATTERHORN：FLOT联合durvalumab可提高胃癌的pCR率
Medicom Conference Report ASCO GI 2024 Pub Date : 2024-02-13 DOI: 10.55788/ae59aeb7
Robert van den Heuvel
{"title":"MATTERHORN: FLOT plus durvalumab leads to high pCR rate in gastric cancer","authors":"Robert van den Heuvel","doi":"10.55788/ae59aeb7","DOIUrl":"https://doi.org/10.55788/ae59aeb7","url":null,"abstract":"","PeriodicalId":516902,"journal":{"name":"Medicom Conference Report ASCO GI 2024","volume":"25 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书